Sites
IRB Review of Virtual Trial Technologies
What are some of the key issues IRBs face when reviewing research that includes virtual trial technology? Read more:
Q&A – Site and Patient Engagement
CEO Gadi Saarony and Deb Tatton, Parexel Senior VP of Global Clinical Operations, discuss site and patient engagement. Read more:
Q&A – The Evolving Role of Technology
CEO Gadi Saarony and Deb Tatton, Parexel Senior VP of Global Clinical Operations, discuss the evolving role of technology in research. Read more:
Accelerating the Recovery – Design and IRB Review of Safety Monitoring Plans During COVID-19
COVID-19 is rapidly changing the way research is conducted, namely how to conduct effective participant safety monitoring at a distance. Read more:
The Opioid Crisis in America
Combating the opioid crisis requires urgent, evidence-based approaches that address clinical, research, and education issues. Read more:
12 Items Auditors Look for When Reviewing an Investigator Site File
Ensure your ISF is complete and avoid findings with these examples of specifically what auditors/inspectors look for during an audit. Read more:
Fitting Your Needs: Pandemic-Proofing Protocols
The COVID-19 pandemic forced organizations to adjust to continue high-quality research, positioning research to be more patient centric and streamlined.
Introducing Fireside Chats: Conversations On Burning Research Topics
Advarra is excited to introduce Fireside Chats, a series of virtual conversations. Fireside Chat is an informal conversation between an Advarra representative, and a clinical research thought leader.
Human Research Protection Program Services
Download our info sheet to learn how Advarra can revitalize your human research protection program (HRPP) with customized consulting support
Q&A – The New Normal: Considerations for Restarting Research
Experts answer some of the most popular audience questions from the recent webinar The New Normal: Considerations for Restart Research. Read more:
Q&A Part 1 – Gene Therapy Research in the Age of COVID-19
Panelists from Advarra’s inaugural virtual symposium participated in a Q&A session to address questions submitted by the audience. Read part 1:
Q&A Part 2 – Gene Therapy Research in the Age of COVID-19
Expert panelists from Advarra’s gene therapy virtual symposium address some of the most popular questions submitted by the audience. Read part 2: